Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

EMA Issues Positive Recommendations for 6 Drugs to European Commission

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

Six new drugs have scored wins at the European Medicines Agency, scooping up recommendations for marketing authorization from the Committee for Medicinal Products for Human Use. Source: International Pharmaceutical Regulatory…

Continue ReadingEMA Issues Positive Recommendations for 6 Drugs to European Commission

Trade Deal Signing Sets the Stage for New Biologics Exclusivity Policy

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

With 12 nations signing off on the Trans-Pacific Partnership, the clock has started on ratification of the treaty providing up to eight years of exclusivity for biologics. Source: International Pharmaceutical…

Continue ReadingTrade Deal Signing Sets the Stage for New Biologics Exclusivity Policy

NHS England Plans to Investigate Alleged Staff Ties to Drugmakers

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

An NHS England spokesperson confirmed Feb. 18 that the agency will investigate whether more than 130 NHS staff involved in assessing drugs were also paid as consultants by drugmakers. Source:…

Continue ReadingNHS England Plans to Investigate Alleged Staff Ties to Drugmakers

EMA Spells Out Disclosure Policy for Clinical Data Set for Publication

  • Post author:Sam
  • Post published:March 17, 2016
  • Post category:International Pharmaceutical Regulatory Monitor

Drugmakers submitting anonymized clinical data in applications to the EMA must keep up on technology advances that could put that data at risk for re-identification. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingEMA Spells Out Disclosure Policy for Clinical Data Set for Publication
  • Go to the previous page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.